From: Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review
Author | Year | Study design | Ovarian Cancer Cases (n) | Overall result RR (95% CI) |
---|---|---|---|---|
Harris | 2016 | Case–control (US) | 1513 | 1.0 (0.60–1.5) |
Gottschau | 2015 | Registry Cohort (Danish) | 10 | 1.8 (0.8–3.2)a |
Shen | 2015 | Registry Cohort (Taiwan) | 11 | 1.0 (0.2–4.6)a |
Barryb | 2014 | Meta-analysis | 3363 | 1.4 (0.9–2.2)a |
Bodmer | 2011 | Case–control (UK) | 1611 | 1.6 (0.7–4.1)a |
Brintonc | 2010 | Cohort (US) | 12 | 1.8 (0.9–3.1)a |
Olsen | 2008 | Case–control (Australia) | 1276 | 1.1 (0.6–2.0) |
Schildkraut | 1996 | Case–control (US) | 476 | 2.4 (1.0–5.9)a |
Rossing | 1994 | Cohort (US) | 11 | 2.4 (0.2–22.5) |